By Glen S. Ramos
MANILA — Lucena City in the province of Quezon posted the highest vaccination coverage at 36.3% (1,387 out of 3,821 health care workers) against Covid-19 since the start of the vaccine roll-out last March 1, 2021, the highest in the region while Quezon province has the lowest coverage rate with only 2.9% (330 out of 11,311).
Department of Health (DOH)–CALABARZON (Cavite, Laguna, Batangas, Rizal, Quezon) Regional Director Eduardo C. Janairo disclosed that of the total 86,425 total eligible population for Priority Group A1 (i.e., health care workers (HCWs) in hospitals and infirmaries), a total of 13,311 individuals, or 15.4% were already vaccinated.
The coverage rate for Sinovac is at 5.9% (5,129) and 9.5% (13,311) for AstraZeneca.
“All provinces are already implementing the vaccination campaign and we have 42 implementing sites registered in the COVID-19 Bakuna Center Registry (CBCR) that are currently conducting vaccination in the region.”
“We have six vaccination sites in Cavite, 12 in Laguna, 11 in Batangas, 7 in Rizal, 3 in Quezon and 3 in Lucena City where our HCWs can visit anytime to get immunized, he emphasized.
CALABARZON received a total of 94,860 vaccine doses for first and second dose use, 19.0% (18,060 doses) of Sinovac and 81.0% (76,800 doses) of AstraZeneca that are sufficient for 47,430 individuals.
“We have recorded deferrals and refusals during the health screenings but slowly and surely the importance of getting the vaccine and having protection against the virus outweighs the negative response of our health care workers and eventually they volunteer to be vaccinated,”
“Since the start of the roll-out there have been real threat reported from the vaccines, and most individuals who receive them, whether Sinovac or AstraZeneca came out safe after vaccination.”
“I encouraged our medical front liners to avail themselves of the vaccine against Covid, especially now that we are facing another surge. This is not only for your protection but also for your family as well,” he concluded. (AI/MTVN)